Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disease-modifying agents in multiple sclerosis.
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β
Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies.
Therapeutic strategies in multiple sclerosis: A focus on neuroprotection and repair and relevance to schizophrenia.
Experimental Autoimmune Encephalomyelitis in Marmosets.
The role of dendritic cells in autoimmunity.
Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.
Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study.
The correlation of HLA-G with multiple sclerosis.
New tools for studying microglia in the mouse and human CNS.
B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
Pharmacological treatments for fatigue associated with palliative care.
Rotation-invariant multi-contrast non-local means for MS lesion segmentation.
Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis.
Correction: An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.
Protein-based classifier to predict conversion from clinically isolated syndrome to multiple sclerosis.
Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells.
Remyelination of the Corpus Callosum by Olfactory Ensheathing Cell in an Experimental Model of Multiple Sclerosis.
The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane.
Cognitive Impairment Occurs in Children and Adolescents With Multiple Sclerosis: Results From a United States Network.
VIP and PACAP: Neuropeptide modulators of CNS inflammation, injury, and repair.
Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures.
Stability of rating scale response category interpretations in neurological disorders.
Optic neuritis: From magnocellular to cognitive residual dysfunction.
Pages
« first
‹ previous
…
511
512
513
514
515
516
517
518
519
…
next ›
last »